description): As the health care delivery landscape has changed, academic medical centers have begun to demand from their faculty a progressive increase in the time dedicated to revenue-generating patient care. In effect, this has resulted in a reduction in the amount of time dedicated to clinical investigation and the mentoring of beginning investigators. While the applicant (i.e., the Candidate) has had extensive experience in both patient-oriented research (studying androgen excess disorders) and the mentoring of beginning clinical investigators (M.D. clinical, research and Postdoctoral Fellows; undergraduate, graduate and medical students; and residents), the need for increased patient care revenue has begun to erode these abilities. The Candidate now requests additional salary support to continue and expand these investigative and teaching efforts, and to fund some the students' didactic expenses. A mentoring plan is proposed with the broad goals of producing a physician with the clinical, laboratory, and intellectual skills necessary to develop into an accomplished academician, teacher and independent clinical researcher. The specific training objectives include: i) selection and design of a clinical research proposal; ii) evaluation of existing knowledge; iii) the recruitment, study and retention of study subjects; iv) data analysis; v) the performance, application and trouble-shooting of various in vivo dynamic tests; vi) the performance, application and quality control of basic laboratory techniques; manuscript preparation and submission; vii) grant writing; and viii) teaching, lecturing, and preparation of presentations. An Advisory Committee is proposed to assist in assessing potential candidates for mentoring, and monitoring the students' progress. The candidate's research, also to be used for mentoring, is supported by NIH grant 2R01-HD29364-05A1 (Adrenal Androgen [AA] Excess in the Polycystic Ovary Syndrome (PCOS]). The study has the long-term objective of elucidating the etiology of AA excess in the genesis of the PCOS.
The specific aims are to determine: i) the prevalence of AA excess in PCOS, using age/race specific normative limits for AA levels; ii) the long-term within-subject variability of AA levels, and their response to ACTH stimulation, in patients with PCOS and normal women; iii) the relative prevalence of the CYPI7 alleles in PCOS patients w/ and w/o AA excess, and in controls; and iv) the heritability of AA levels, and their response to ACTH stimulation, in PCOS w/ and w/o AA excess, and controls. The institution has committed to releasing the Candidate from other duties in order for him to dedicate at least 50% of his time to the research and mentoring activities.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
1K24HD001346-01
Application #
6029586
Study Section
Special Emphasis Panel (ZHD1-PRG-G (RH))
Program Officer
Parrott, Estella C
Project Start
2000-04-05
Project End
2005-03-31
Budget Start
2000-04-05
Budget End
2001-03-31
Support Year
1
Fiscal Year
2000
Total Cost
$87,198
Indirect Cost
Name
University of Alabama Birmingham
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Ketefian, Aline; Jones, Michelle R; Krauss, Ronald M et al. (2016) Association study of androgen signaling pathway genes in polycystic ovary syndrome. Fertil Steril 105:467-73.e4
Hayes, M Geoffrey; Urbanek, Margrit; Ehrmann, David A et al. (2015) Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun 6:7502
Brower, Meredith A; Jones, Michelle R; Rotter, Jerome I et al. (2015) Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals. J Clin Endocrinol Metab 100:E182-6
Xu, Ning; Geller, David H; Jones, Michelle R et al. (2015) Comprehensive assessment of expression of insulin signaling pathway components in subcutaneous adipose tissue of women with and without polycystic ovary syndrome. J Clin Transl Endocrinol 2:99-104
Ezeh, Uche; Yildiz, Bulent O; Azziz, Ricardo (2013) Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J Clin Endocrinol Metab 98:E1088-96
Wang, Rui; Goodarzi, Mark O; Xiong, Ting et al. (2012) Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis. Mol Hum Reprod 18:498-509
Layden, Brian T; Yalamanchi, Sudha K; Wolever, Thomas Ms et al. (2012) Negative association of acetate with visceral adipose tissue and insulin levels. Diabetes Metab Syndr Obes 5:49-55
Jones, Michelle R; Chazenbalk, Gregorio; Xu, Ning et al. (2012) Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility. J Clin Endocrinol Metab 97:E1750-7
Goodarzi, Mark O; Jones, Michelle R; Li, Xiaohui et al. (2012) Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet 49:90-5
Cook, Heather; Brennan, Kathleen; Azziz, Ricardo (2011) Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism? Fertil Steril 96:1266-70.e1

Showing the most recent 10 out of 58 publications